Like other GLP-1s, liraglutide is not recommended during pregnancy or breastfeeding.13 Tirzepatide (Mounjaro, Zepbound) Tirzepatide is a dual agonist that targets both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, making it distinct from other single-pathway medications
[2] [5] Leukopenia, including agranulocytosis, and thrombocytopenia have been reported during spironolactone therapy
Patients looking for physician-guided care can also learn more about our safe & effective weight loss solutions , which combine medical expertise with personalized support
Pre-donation DonorKids QL found similar percentages of poor donor HRQoL analysis of additional timepoints is pending
When you take Ozempic or compounded semaglutide, increased GLP-1 signaling changes how your body manages energy
A growing body of research suggests that the loss of cardiac regenerative capacity is closely related to metabolic shifts in energy sources
